JENNIFER HORNE: Open Payments
NPI 1174191571 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 91 payments from 18 companies in 2025. Trend: 2023 $378 · 2024 $1,366 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 16 | $361 |
| PFIZER INC. | 15 | $295 |
| Novartis Pharmaceuticals Corporation | 10 | $260 |
| Alnylam Pharmaceuticals Inc. | 7 | $187 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Actelion Pharmaceuticals US, Inc. | 5 | $127 |
| Novo Nordisk Inc | 5 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $112 |
| ABIOMED | 3 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
Products named: Attruby, LEQVIO, VYNDAQEL, ELIQUIS, ONPATTRO, Wegovy, Kerendia, OPSYNVI.
Industry payments across MA — which companies pay providers there.
